Abstract

We have determined that expression of the pseudokinase NRBP1 positively associates with poor prognosis in triple negative breast cancer (TNBC) and is required for efficient migration, invasion and proliferation of TNBC cells in culture as well as growth of TNBC orthotopic xenografts and experimental metastasis. Application of BioID/MS profiling identified P-Rex1, a known guanine nucleotide exchange factor for Rac1, as a NRBP1 binding partner. Importantly, NRBP1 overexpression enhanced levels of GTP-bound Rac1 and Cdc42 in a P-Rex1-dependent manner, while NRBP1 knockdown reduced their activation. In addition, NRBP1 associated with P-Rex1, Rac1 and Cdc42, suggesting a scaffolding function for this pseudokinase. NRBP1-mediated promotion of cell migration and invasion was P-Rex1-dependent, while constitutively-active Rac1 rescued the effect of NRBP1 knockdown on cell proliferation and invasion. Generation of reactive oxygen species via a NRBP1/P-Rex1 pathway was implicated in these oncogenic roles of NRBP1. Overall, these findings define a new function for NRBP1 and a novel oncogenic signalling pathway in TNBC that may be amenable to therapeutic intervention.

Details

Title
The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer
Author
Yang, Xue 1   VIAFID ORCID Logo  ; Cruz, Miguel I. 1   VIAFID ORCID Logo  ; Nguyen, Elizabeth V. 1 ; Huang, Cheng 2 ; Schittenhelm, Ralf B. 2   VIAFID ORCID Logo  ; Luu, Jennii 3 ; Cowley, Karla J. 3   VIAFID ORCID Logo  ; Shin, Sung-Young 1   VIAFID ORCID Logo  ; Nguyen, Lan K. 1   VIAFID ORCID Logo  ; Lim Kam Sian, Terry C. C. 1   VIAFID ORCID Logo  ; Clark, Kimberley C. 1   VIAFID ORCID Logo  ; Simpson, Kaylene J. 4 ; Ma, Xiuquan 1   VIAFID ORCID Logo  ; Daly, Roger J. 1   VIAFID ORCID Logo 

 Monash University, Cancer Program, Biomedicine Discovery Institute, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, Department of Biochemistry and Molecular Biology, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 Monash University, Department of Biochemistry and Molecular Biology, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, Monash Proteomics and Metabolomics Facility, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 Peter MacCallum Cancer Centre, Victorian Centre for Functional Genomics, Melbourne, Australia (GRID:grid.1055.1) (ISNI:0000000403978434) 
 Peter MacCallum Cancer Centre, Victorian Centre for Functional Genomics, Melbourne, Australia (GRID:grid.1055.1) (ISNI:0000000403978434); University of Melbourne, Sir Peter MacCallum Department of Oncology, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
Pages
833-847
Publication year
2023
Publication date
Mar 2023
Publisher
Nature Publishing Group
ISSN
09509232
e-ISSN
14765594
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2785499417
Copyright
© The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.